Corporate governance in Diamyd Medical AB is based on the Swedish Companies Act and other relevant rules and recommendations for public companies.

The Annual General Meeting is Diamyd Medical’s highest decision-making body. It passes resolutions on central questions such as the adoption of the income statement and balance sheet, the election of Board members and the Chairman of the Board, indemnity for Board members and the CEO, changes to the Articles of Association, the appointment of the auditor and the adoption of compensation guidelines for the Company's key executives. The formalities of the Annual General Meeting are primarily regulated by the Articles of Incorporation.

The latest Annual General Meeting was held on November 26, 2015. Documents from the three latest AGM:s can be downloaded below.

Annual General Meeting Documents

Kallelse till årsstämma 2015

Handlingar inför årsstämma 2015

Årsstämmoprotokoll 2015

The Nomination Committee of Diamyd Medical AB consists of the two largest shareholders:
Anders Essen-Möller and Bertil Lindkvist.

E-mails to the Nomination Committee:
Diamyd Medical’s auditors are BDO AB. Johan Pharmanson is the principal auditor. Johan Pharmanson is a member of FAR and has been an authorized public accountant since 1994. Partner of BDO since 1998.
The information below is related to previous rights issues in Diamyd Medical and are not to be regarded as public offers. Documents are available in Swedish only.
Informationsmaterial – Inbjudan till teckning av aktier i Diamyd Medical AB (publ) - 2016

Informationsmaterial – Inbjudan till teckning av aktier i Diamyd Medical AB (publ) - 2013

Articles of Incorporation

Articles of Incorporation for Diamyd Medical AB adopted at an Extra General Meeting of Shareholders on April 19, 2013.

   Bolagsordning för Diamyd Medical AB  

Company Description

Company Description for Diamyd Medical AB (publ), prior to listing on Nasdaq Stockholm First North. Available as a downloadable PDF in Swedish.

   Bolagsbeskrivning för Diamyd Medical AB